Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anidulafungin vs Caspofungin in Deep Tissue Candida Infection
NCT00805740Phase 3Terminated
- Sponsor
- Pfizer
- Start
- Apr 2009
- Primary completion
- Jun 2012
- Modality
- Small Molecules, Cyclic Peptides
- Countries
- 9
01
Overview
A Phase 3 trial of anidulafungin in invasive candidiasis, sponsored by Pfizer. Started Apr 2009; status: terminated.
02
Drugs
anidulafungin
03
Conditions
invasive candidiasis
Beyond the preview
Go deeper on NCT00805740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00805740.